Renalytix Plc Share Price
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
London S.E.
15:01:56 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5.431 GBX | -3.02% |
|
-6.36% | -7.95% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 13.34M 11.97M 11.06M 10.02M 18.72M 1.27B 18.94M 132M 52.68M 665M 50.05M 48.99M 2.11B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 16.09M 14.88M 13.47M 25.17M 1.71B 25.48M 178M 70.85M 894M 67.31M 65.89M 2.84B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 day | -3.02% | ||
| 1 week | -6.36% | ||
| Current month | -10.97% | ||
| 1 month | -10.23% | ||
| 3 months | +104.94% | ||
| 6 months | +201.72% | ||
| Current year | -7.95% |
| 1 week | 5.15 |  | 6.1 |
| 1 month | 5.1 | | 6.3 |
| Current year | 1.6 | | 6.57 |
| 1 year | 1.6 | | 8.4 |
| 3 years | 1.6 | | 74.9 |
| 5 years | 1.6 | | 909.7 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 14/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 27/05/2024 |
Howard Doran
PSD | President | 65 | 29/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 14/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 14/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/02/26 | Buy | Founder | 250 | 0.0001% | ||
| 13/02/26 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 13/02/26 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.02% | -6.36% | -34.17% | -87.22% | 45.01M | |
| +0.89% | +4.89% | +27.10% | +63.47% | 260B | |
| +1.31% | +3.21% | +10.80% | +28.10% | 165B | |
| +0.77% | +0.94% | -16.66% | +73.33% | 154B | |
| -1.34% | -8.86% | -58.19% | -16.21% | 61.49B | |
| +3.19% | +4.88% | +14.26% | +51.52% | 52.9B | |
| +0.58% | +2.73% | -13.07% | -6.27% | 52.84B | |
| -1.59% | -3.20% | +8.91% | +64.08% | 51.46B | |
| +0.27% | +4.56% | +26.97% | +79.72% | 51.16B | |
| +0.82% | +5.57% | +40.04% | +103.20% | 46.85B | |
| Average | +0.19% | +1.67% | +0.60% | +35.37% | 89.58B | |
| Weighted average by Cap. | +0.73% | +1.41% | +7.22% | +51.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.05 1.9 1.72 3.21 218.01 3.25 22.7 9.04 114.08 8.59 8.41 362.16 | 3 2.69 2.49 2.25 4.21 285.72 4.26 29.75 11.85 149.51 11.26 11.02 474.65 |
| Net income | -33.46M -30.02M -27.75M -25.13M -46.96M -3.19B -47.52M -332M -132M -1.67B -126M -123M -5.29B | -20.4M -18.3M -16.92M -15.33M -28.63M -1.94B -28.98M -202M -80.59M -1.02B -76.55M -74.94M -3.23B |
| Net Debt | 3.86M 3.46M 3.2M 2.9M 5.41M 367M 5.48M 38.23M 15.23M 192M 14.47M 14.16M 610M | 4.6M 4.13M 3.82M 3.46M 6.46M 438M 6.53M 45.62M 18.17M 229M 17.26M 16.9M 728M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | GBX 5.431 | -3.02% | 595,142 |
| 28/10/26 | GBX 5.600 | -5.88% | 2,985,462 |
| 27/10/26 | GBX 5.950 | 0.00% | 616,207 |
| 26/10/26 | GBX 5.950 | -0.83% | 914,935 |
| 23/10/26 | GBX 6.000 | +3.45% | 2,485,415 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
